Dimethyl (2-oxo-3-phenoxypropyl)phosphonate, 95.0%, 5g

2-(1-((2-(1H-indol-3-yl)ethyl)amino)ethylidene)-1H-indene-1,3(2H)-dione, 90%, 1g

N-Methyl-2-(pyridin-2-yl)-N-(2-(pyridin-2-yl)ethyl)ethanamine, 97.0%, 50mg

3,4-Difluoro-4'-(4'-propyl-[1,1'-bi(cyclohexan)]-4-yl)-1,1'-biphenyl, 98+%, 25g

(6-Chloro-pyridin-3-yl)-acetic acid, 97.0%, 5g

5-Bromo-3-(tert-butyl)-2-hydroxybenzaldehyde, 95.0%, 10g

Wide angle WF 15x/15 mm eyepiece, Ø 30 mm tube

Potassium (R)-oxirane-2-carboxylate, 95.0%, 5g

2,5-Difluorobenzenesulfonamide, 98.0%, 1g

1-Methyl-4-(3-trifluoromethyl-pyridin-2-yl)-piperazine, 95.0%, 1g

Methyl 5-methyl-4-oxo-3,4-dihydrothieno[2,3-d]-pyrimidine-6-carboxylate, 90.0%, 1g

Imidazole>98.0%(T)500g

Methyl 1-(4-fluorophenyl)cyclobutanecarboxylate, 97%, 5g